Arabic Arabic English English French French German German
dark

Eyenovia to Participate in a Presbyopia Panel Discussion at Eyecelerator 2021

Eyenovia, Inc., a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print therapeutics, announced that Eyenovia will be featured at the Company Showcase on July 22 at the Eyecelerator@ASCRS and will participate in a panel discussion, entitled, “Presbyopia: Everybody gets it.. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Kadmon’s Chronic GVHD Drug Wins First FDA Approval for Company

Next Post

InterSystems Recognised as a Leader by Independent Research Firm in Multimodel Data Platforms Evaluation

Related Posts
Total
0
Share